Search Results - "Mozziconacci, M.J"

P-006 Prognostic value of TP53 gene mutations in higher-risk MDS treated with azacitidine (AZA) by Bally, C, Ades, L, Renneville, A, Mozziconacci, M.J, Preudhomme, C, DeThé, H, Lehmann-Che, J, Fenaux, P

Get full text

P-023 Incidence and prognostic value of TP53 mutations in IPSS low and INT 1 (lower risk) MDS with del 5q by Bally, C, Ades, L, Renneville, A, Preudhomme, C, Raynaud, S, Cluzeau, T, Eclache, V, Hunault-Berger, M, Stamoullas, A, Fontenay, M, Mozziconacci, M.J, De Thé, H, Fenaux, P, Lehmann-Che, J

Get full text

Mutations of ASXL1 gene in myeloproliferative neoplasms by Carbuccia, N, Murati, A, Trouplin, V, Brecqueville, M, Adélaïde, J, Rey, J, Vainchenker, W, Bernard, O A, Chaffanet, M, Vey, N, Birnbaum, D, Mozziconacci, M J

Get full text

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution by Cabagnols, X, Defour, J P, Ugo, V, Ianotto, J C, Mossuz, P, Mondet, J, Girodon, F, Alexandre, J H, Mansier, O, Viallard, J F, Lippert, E, Murati, A, Mozziconacci, M J, Saussoy, P, Vekemans, M C, Knoops, L, Pasquier, F, Ribrag, V, Solary, E, Plo, I, Constantinescu, S N, Casadevall, N, Vainchenker, W, Marzac, C, Bluteau, O

Get full text

Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias by Carbuccia, N, Trouplin, V, Gelsi-Boyer, V, Murati, A, Rocquain, J, Adélaïde, J, Olschwang, S, Xerri, L, Vey, N, Chaffanet, M, Birnbaum, D, Mozziconacci, M J

Get full text

NUP98-HMGB3: a novel oncogenic fusion by Petit, A, Ragu, C, Della-Valle, V, Mozziconacci, M J, Lafage-Pochitaloff, M, Soler, G, Schluth, C, Radford, I, Ottolenghi, C, Bernard, O A, Penard-Lacronique, V, Romana, S P

Get full text

Alterations of NFIA in chronic malignant myeloid diseases by Bernard, F, Gelsi-Boyer, V, Murati, A, Giraudier, S, Trouplin, V, Adélaïde, J, Rey, J, Olschwang, S, Vainchenker, W, Chaffanet, M, Vey, N, Mozziconacci, M J, Birnbaum, D

Get full text

Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies by Adélaïde, J, Gelsi-Boyer, V, Rocquain, J, Carbuccia, N, Birnbaum, D J, Finetti, P, Bertucci, F, Mozziconacci, M J, Vey, N, Birnbaum, D, Chaffanet, M

Get full text

Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH) by Luquet, I, Laï, J L, Barin, C, Baranger, L, Bilhou-Nabera, C, Lippert, E, Gervais, C, Talmant, P, Cornillet-Lefebvre, P, Perot, C, Nadal, N, Mozziconacci, M J, Lafage-Pochitaloff, M, Eclache, V, Mugneret, F, Lefebvre, C, Herens, C, Speleman, F, Poirel, H, Tigaud, I, Cabrol, C, Rousselot, P, Daliphard, S, Imbert, M, Garand, R, Geneviève, F, Berger, R, Terre, C

“…A series of 38 patients with acute myeloblastic leukemia (AML) with 49 or more chromosomes and without structural abnormalities was selected within the Groupe…”
Get full text

t(1;19) in a M4-ANLL by Vagner-Capodano, A M, Mozziconacci, M J, Zattara-Cannoni, H, Guitard, A M, Thuret, I, Michel, G

Get more information

Myelofibrosis in a child suffering from a hypereosinophilic syndrome with trisomy 8: response to corticotherapy by Michel, G, Thuret, I, Capodano, A M, Scheiner, C, Guitard, A M, Mozziconacci, M J, Fossat, C, Perrimond, H

“…The idiopathic hypereosinophilic syndrome (IHS) is extremely rare in childhood and relationships of this syndrome with myeloproliferative diseases are…”
Get more information